The Patent Finder

Methods of Administering Amantadine

Adamas Pharma, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 61/836,082, filed Jun 17, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,646,456Methods of Administering Amantadine
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
US 11,903,908Methods of Administering Amantadine
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
US 10,154,971Methods of Administering Amantadine
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
Application 16/841,452Methods of Administering Amantadine
Abandoned
Abandoned Nov 17, 2020
Adamas Pharma, LLCAbandonedAbandoned Nov 17, 2020
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Adamas Pharma, LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited